When is an outbreak not an outbreak? Fit, divergent strains of mycobacterium tuberculosis display independent evolution of drug resistance in a large london outbreak

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 3, 2013, Pages 543-549

  Shorten, R J ^a,b   Mcgregor, A C ^c   Platt, S ^d   Jenkins, C ^b,d   Lipman, M C I ^b   Gillespie, S H ^e   Charalambous, B M ^b   Mchugh, T D ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Fitness; MIRU; RFLP; Transmission

Indexed keywords

CLARITHROMYCIN; ETHIONAMIDE; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; DRUG RESISTANT TUBERCULOSIS; EPIDEMIC; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNITED KINGDOM;

ANTITUBERCULAR AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; GENETIC VARIATION; GENOTYPE; HUMANS; ISONIAZID; LONDON; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUBERCULOSIS;

EID: 84873602219     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks430     Document Type: Article

References (29)

1. Ruddy MC, Davies AP, Yates MD et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax 2004; 59: 279-85.
2. Maguire H, Brailsford S, Carless J et al. Large outbreak of isoniazid-monoresistant tuberculosis in London, 1995 to 2006: case-control study and recommendations. Euro Surveill 2011; 16: pii 19830.
3. Neely F, Maguire H, Le BF et al. High rate of transmission among contacts in large London outbreak of isoniazid mono-resistant tuberculosis. J Public Health (Oxf) 2010; 32: 44-51.
4. NICE Tuberculosis Guidelines 2011. National Institute for Health and Clinical Excellence. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. http://guidance.nice. org.uk/CG117/NICEGuidance/pdf/English (5 October 2012, date last accessed).
5. Middlebrook G, Cohn ML. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 1953; 118: 297-9.
6. Mitchison DA. Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in guinea-pigs. Br Med J 1954; 1: 128-30.
7. Gillespie SH, McHugh TD. The biological cost of antimicrobial resistance. Trends Microbiol 1997; 5: 337-9.
8. O'Sullivan DM, McHugh TD, Gillespie SH. Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture. J Med Microbiol 2010; 59: 1533-5.
9. Moore FB, Rozen DE, Lenski RE. Pervasive compensatory adaptation in Escherichia coli. Proc Biol Sci 2000; 267: 515-22.
10. Reynolds MG. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 2000; 156: 1471-81.
11. Maisnier-Patin S, Andersson DI. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res Microbiol 2004; 155: 360-9.
12. Sherman DR, Mdluli K, Hickey MJ et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 1996; 272: 1641-3.
13. Gagneux S, Burgos MV, Deriemer K et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2006; 2: e61.
14. van Soolingen D, de Haas PE, van Doorn HR et al. Mutations at amino acid position 315 of the katG gene are associated with highlevel resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis 2000; 182: 1788-90.
15. van Doorn HR, de Haas PE, Kremer K et al. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. Clin Microbiol Infect 2006; 12: 769-75.
16. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007; 7: 328-37.
17. Glynn JR, Whiteley J, Bifani PJ et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843-9.
18. Borrell S, Gagneux S. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1456-66.
19. McHugh TD, Batt SL, Shorten RJ et al. Mycobacterium tuberculosis lineage: a naming of the parts. Tuberculosis 2005; 85: 127-36.
20. van Embden JD, Cave MD, Crawford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
21. Supply P, Allix C, Lesjean S et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 4498-510.
22. O'Sullivan DM. Evolution of the mechanisms of drug resistance in M. tuberculosis. PhD thesis, University College London, 2007.
23. Telenti A, Honoré N, Bernasconi C et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997; 35: 719-23.
24. Jenkins C, Claxton AP, Shorten RJ et al. Rifampicin resistance in tuberculosis outbreak, London, England. Emerg Infect Dis 2005; 11: 931-4.
25. Youmans GP, Youmans AS. A method for the determination of the rate of growth of tubercle bacilli by the use of small inocula. J Bact 1949; 58: 247-55.
26. de Boer AS, Borgdorff MW, de Haas PE et al. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J Infect Dis 1999; 180: 1238-44.
27. Maguire H, Ruddy M, Bothamley G et al. Multidrug resistance emerging in North London outbreak. Thorax 2006; 61: 547-8.
28. Yeh RW, Ponce de LA, Agasino CB et al. Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis 1998; 177: 1107-11.
29. Gagneux S, Long CD, Small PM et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006; 312: 1944-6.